These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 32701815)

  • 1. Nivolumab-Induced Periaortitis Demonstrated by FDG PET/CT.
    Hotta M; Naka G; Minamimoto R; Takeda Y; Hojo M
    Clin Nucl Med; 2020 Nov; 45(11):910-912. PubMed ID: 32701815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison Between
    Rossi G; Bauckneht M; Genova C; Rijavec E; Biello F; Mennella S; Dal Bello MG; Cittadini G; Bruzzi P; Piva R; Ceriani V; Sambuceti G; Lopci E; Morbelli S; Grossi F
    J Nucl Med; 2020 Jul; 61(7):990-998. PubMed ID: 31806768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency and imaging features of abdominal immune-related adverse events in metastatic lung cancer patients treated with PD-1 inhibitor.
    Alessandrino F; Sahu S; Nishino M; Adeni AE; Tirumani SH; Shinagare AB; Awad MM
    Abdom Radiol (NY); 2019 May; 44(5):1917-1927. PubMed ID: 30790009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early assessment with
    Tabei T; Nakaigawa N; Kaneta T; Ikeda I; Kondo K; Makiyama K; Hasumi H; Hayashi N; Kawahara T; Izumi K; Osaka K; Muraoka K; Teranishi JI; Miyoshi Y; Yumura Y; Uemura H; Kobayashi K; Inoue T; Yao M
    BMC Cancer; 2019 Apr; 19(1):298. PubMed ID: 30940117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FDG-PET in the evaluation of response to nivolumab in recurrent non-small-cell lung cancer.
    Higuchi M; Owada Y; Inoue T; Watanabe Y; Yamaura T; Fukuhara M; Hasegawa T; Suzuki H
    World J Surg Oncol; 2016 Sep; 14(1):238. PubMed ID: 27595749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nivolumab-Induced Pneumonitis in Patient With Metastatic Melanoma Showing Complete Remission on 18F-FDG PET/CT.
    Razzouk-Cadet M; Picard A; Grangeon-Chapon C; Lacour JP; Montaudié H
    Clin Nucl Med; 2019 Oct; 44(10):806-807. PubMed ID: 31306191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic activity by
    Kaira K; Higuchi T; Naruse I; Arisaka Y; Tokue A; Altan B; Suda S; Mogi A; Shimizu K; Sunaga N; Hisada T; Kitano S; Obinata H; Yokobori T; Mori K; Nishiyama M; Tsushima Y; Asao T
    Eur J Nucl Med Mol Imaging; 2018 Jan; 45(1):56-66. PubMed ID: 28828507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aortic rupture following acute aortitis in a patient with head and neck carcinoma treated with nivolumab: a rare but severe immune-related adverse event.
    Ohno Y; Ueki Y; Oshima S; Omata J; Yokoyama Y; Takahashi T; Shodo R; Yamazaki K; Horii A
    Eur Arch Otorhinolaryngol; 2024 Apr; 281(4):2037-2040. PubMed ID: 38308762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between inflammation and progression of an abdominal aortic aneurysm in a rabbit model based on 18F-FDG PET/CT imaging.
    Nie MX; Zhang XH; Yan YF; Zhao QM
    Vascular; 2018 Dec; 26(6):571-580. PubMed ID: 29673292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful treatment of immune checkpoint inhibitor-related periaortitis.
    Bührer ED; Alberts IL; Christ L; Özdemir BC
    Swiss Med Wkly; 2024 Feb; 154():3631. PubMed ID: 38579296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The immune-metabolic-prognostic index and clinical outcomes in patients with non-small cell lung carcinoma under checkpoint inhibitors.
    Castello A; Toschi L; Rossi S; Mazziotti E; Lopci E
    J Cancer Res Clin Oncol; 2020 May; 146(5):1235-1243. PubMed ID: 32048008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The use of positron emission tomography (18F-FDG PET) in diagnosing chronic periaortitis].
    Nemec P; Rehák Z; Fabián P; Soucek M
    Vnitr Lek; 2008 Nov; 54(11):1093-9. PubMed ID: 19069683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients.
    Kanzaki R; Higashiyama M; Maeda J; Okami J; Hosoki T; Hasegawa Y; Takami M; Kodama K
    Interact Cardiovasc Thorac Surg; 2010 Jun; 10(6):1009-14. PubMed ID: 20197344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nivolumab-Associated Pulmonary and Bone Sarcoidosis in a Patient With Melanoma of Unknown Primary.
    Tulbah RI; Rowe SP; Solnes LB; Javadi MS
    Clin Nucl Med; 2019 Sep; 44(9):e519-e521. PubMed ID: 31348077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High Structural Stress and Presence of Intraluminal Thrombus Predict Abdominal Aortic Aneurysm 18F-FDG Uptake: Insights From Biomechanics.
    Huang Y; Teng Z; Elkhawad M; Tarkin JM; Joshi N; Boyle JR; Buscombe JR; Fryer TD; Zhang Y; Park AY; Wilkinson IB; Newby DE; Gillard JH; Rudd JH
    Circ Cardiovasc Imaging; 2016 Nov; 9(11):e004656. PubMed ID: 27903534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FDG PET/CT in Immune-Related Arthritis in a Patient Treated With Nivolumab.
    Bayat M; Doroudinia A; Karam MB; Mehrian P
    Clin Nucl Med; 2023 Mar; 48(3):271-272. PubMed ID: 36252811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic Adaptation of Tumor Immune Response With Nivolumab Demonstrated by 18F-FDG PET/CT.
    Eshghi N; Lundeen TF; Kuo PH
    Clin Nucl Med; 2018 Feb; 43(2):114-116. PubMed ID: 29261621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. (18)F-FDG PET/CT for the detection of large vessel vasculitis in patients with polymyalgia rheumatica.
    Lavado-Pérez C; Martínez-Rodríguez I; Martínez-Amador N; Banzo I; Quirce R; Jiménez-Bonilla J; De Arcocha-Torres M; Bravo-Ferrer Z; Jiménez-Alonso M; López-Defilló JL; Blanco R; González-Gay MA; Carril JM
    Rev Esp Med Nucl Imagen Mol; 2015; 34(5):275-81. PubMed ID: 26159505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aftermath of induced inflammation: acute periaortitis due to nivolumab therapy.
    Roy AK; Tathireddy HR; Roy M
    BMJ Case Rep; 2017 Sep; 2017():. PubMed ID: 28942413
    [No Abstract]   [Full Text] [Related]  

  • 20. Nivolumab Induces Sustained Liver Injury in a Patient with Malignant Melanoma.
    Matsubara T; Nishida T; Higaki Y; Tomita R; Shimakoshi H; Shimoda A; Osugi N; Sugimoto A; Takahashi K; Nakamatsu D; Mukai K; Yamamoto M; Fukui K; Adachi S; Inada M
    Intern Med; 2018 Jun; 57(12):1789-1792. PubMed ID: 29434164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.